Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Inorganic Chemistry

• Publication date

  2006-09-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/IC061008YPMID 17054361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metal-based antitumour drugs in the post genomic era.

  2006cited by this paper
• Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.

  2005cited by this paper
• A Mass Spectrometric and Molecular Modelling Study of Cisplatin Binding to Transferrin

  2005cited by this paper
• In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.

  2005cited by this paper
• Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

  2005cited by this paper
• Ruthenium antimetastatic agents.

  2004cited by this paper
• Cisplatin and platinum drugs at the molecular level. (Review).

  2003cited by this paper
• Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

  2003cited by this paper
• Ovarian cancer: strategies for overcoming resistance to chemotherapy

  2003cited by this paper
• Recent developments in the field of tumor-inhibiting metal complexes.

  2003cited by this paper
• Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.

  2002cited by this paper
• Ruthenium-based compounds and tumour growth control (review).

  2000cited by this paper
• Current status of platinum-based antitumor drugs.

  1999cited by this paper
• Non-platinum chemotherapeutic metallopharmaceuticals.

  1999cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Schiff base complexes derived from Trimethoprim

  2026cites this paper
• Exploring the toxicity of mononuclear piano-stool Ru(II) anticancer agents: A comprehensive literature review

  2025cites this paper
• Understanding the Modes of Action of β‑Ketoiminato Iridium(III) Complexes in Cancer Cells

  2025cites this paper
• Exploring photophysical, photochemical, and photobiological dynamics of binuclear transition metal complexes

  2025cites this paper
• Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate

  2025cites this paper
• Oxidation states in metallocenes: A key mechanistic component in cancer alleviation

  2024cites this paper
• A half sandwich Ru(II)-p-cymene nitrite complex selectively induces cell death in cisplatin-resistant malignant melanoma cells.

  2024cites this paper
• Photocytotoxic kinetically stable ruthenium(II)-N,N-donor polypyridyl complexes of oxalate with anticancer activity against HepG2 liver cancer cells.

  2024cites this paper
• Anticancer agents based on metal organic cages

  2024cites this paper
• Ruthenium(II)–Arene Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic Behavior, and Binding to Biological Molecules

  2023cites this paper
• Interactions of arene ruthenium(II) complexes [η^6-(C_6H_6)Ru(pprip)Cl]^+ and [η^6-(C_6H_6)Ru(H_2iiP)Cl]^+ with RNA triplex poly(U)•poly(A)*poly(U)

  2023cites this paper
• Experimental and computational studies of silver(I) dibenzoylmethane-based complexes, interaction with DNA/RNA/BSA biomolecules, and in vitro cytotoxic activity.

  2023cites this paper
• Half-sandwich iridium(III) and rhodium(III) complexes: synthesis, characterization and antifouling properties

  2023cites this paper
• Fine-tuning the cytotoxicity of ruthenium(ii) arene compounds to enhance selectivity against breast cancers

  2023cites this paper
• Ruthenium arene complexes with chalcone ligands incorporating pyridyl and anthryl units: Synthesis, aqueous stability and interaction with quadruplex DNA

  2023cites this paper
• Systematic review of organometallic half-sandwich complexes: Medicinal application and biological evaluation of anticancer activity

  2023cites this paper
• Anticancer Properties of Ru and Os Half-Sandwich Complexes of N,S Bidentate Schiff Base Ligands Derived from Phenylthiocarbamide.

  2023cites this paper
• Development of Mononuclear (Arene) Ruthenium Complexes as Anticancer Agents: A Review

  2022cites this paper
• New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity.

  2022cites this paper
• Arene Variation of Highly Cytotoxic Tridentate Naphthoquinone-Based Ruthenium(II) Complexes and In-Depth In Vitro Studies

  2022cites this paper
• Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods

  2021cites this paper
• A solid support-based synthetic strategy for the site-selective functionalization of peptides with organometallic half-sandwich moieties.

  2021cites this paper
• Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives

  2021cites this paper
• New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application.

  2021cites this paper
• Synthesis, Characterization, and Biological Activity of Water-Soluble, Dual Anionic and Cationic Ruthenium-Arene Complexes Bearing Imidazol(in)ium-2-dithiocarboxylate Ligands.

  2021cites this paper
• Half-Sandwich Ru(p-cymene) Compounds with Diphosphanes: In Vitro and In Vivo Evaluation As Potential Anticancer Metallodrugs.

  2021cites this paper
• Triazole-Based Half-Sandwich Ruthenium(II) Compounds: From In Vitro Antiproliferative Potential to In Vivo Toxicity Evaluation.

  2021cites this paper
• Synthesis and catalytic applications of Ru(II)-phosphaurotropine complexes with the use of simple water-soluble Ru(II)-precursors

  2021cites this paper
• Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization

  2020cites this paper
• Synthesis, structure and electrochemistry of ruthenium(II) and (III) mono- and bis-oxalato complexes

  2020cites this paper
• Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS

  2020cites this paper
• Homo- and heterodinuclear arene-linked osmium(II) and ruthenium(II) organometallics: probing the impact of metal variation on reactivity and biological activity.

  2020cites this paper
• Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex.

  2020cites this paper
• Synthesis and In Vitro Biological Evaluation of a Second-Generation Multimodal Water-Soluble Porphyrin-RAPTA Conjugate for the Dual-Therapy of Cancers.

  2020cites this paper
• Evaluation of biomolecular interactions and cytotoxic activity of organometallic binuclear Ru(II) complexes of ferrocenyl thiosemicarbazones

  2020influential citation
• The rate of substitution from η6-arene ruthenium(II) complexes

  2020cites this paper
• Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes

  2020cites this paper
• Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review.

  2020cites this paper
• Binuclear ruthenium(II) complexes of 4,4′-azopyridine bridging ligand as anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies

  2019cites this paper
• Organometallic binuclear Ru(II) complexes: Design, synthesis, DNA/BSA binding interactions and in-vitro cytotoxicity against HeLa cell line

  2019cites this paper
• Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies

  2019cites this paper
• Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure

  2019cites this paper
• Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos.

  2019cites this paper
• Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η6-p-cymene) complex in human non-small cell lung cancer via p53-dependent pathway.

  2019cites this paper
• Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC

  2019cites this paper
• Towards Identification of Essential Structural Elements of Organoruthenium(II)-Pyrithionato Complexes for Anticancer Activity.

  2019cites this paper
• Unusual coordination mode of aroyl/acyl thiourea ligands and their π‐arene ruthenium (II) piano‐stool complexes: Synthesis, molecular geometry, theoretical studies and biological applications

  2019cites this paper
• Design, synthesis and in vitro bioactivity of mixed ligand Ru(II) complexes bearing the fluoroquinolone antibacterial agents

  2019cites this paper
• Encapsulation of the Dinuclear Trithiolato‐Bridged Arene Ruthenium Complex Diruthenium‐1 in an Apoferritin Nanocage: Structure and Cytotoxicity

  2019cites this paper
• Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action.

  2019cites this paper
• Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.

  2018cites this paper
• Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity

  2018cites this paper
• Thermal Analysis, Antioxidant and in vitro Antimicrobial Activity of Palladium(II)Complexes with N,Nâ²- Ethylenediamine Bidentate Ester Ligands

  2018cites this paper
• Cytotoxicity of η6-areneruthenium-based molecules to glioblastoma cells and their recognition by multidrug ABC transporters.

  2018cites this paper
• Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.

  2018cites this paper
• Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.

  2018cites this paper
• Polynuclear ruthenium organometallic complexes containing a 1,3,5-triazine ligand: synthesis, DNA interaction, and biological activity

  2018cites this paper
• Organoruthenium(II) Complexes Ameliorates Oxidative Stress and Impedes the Age Associated Deterioration in Caenorhabditis elegans through JNK-1/DAF-16 Signalling

  2018cites this paper
• Half-Sandwich Metal Complexes with β-Diketone-Like Ligands and Their Anticancer Activity

  2018cites this paper
• Ionic η5-Cp-Ruthenium (II) complexes as potential anticancer agents

  2018cites this paper
• Stimuli-Responsive Therapeutic Metallodrugs.

  2018cites this paper
• Mixed ligand ruthenium arene complexes containing N-ferrocenyl amino acids: Biomolecular interactions and cytotoxicity against MCF7 cell line

  2017cites this paper
• Arene–Ruthenium(II) Complexes with Bioactive ortho‐Hydroxydibenzoylmethane Ligands: Synthesis, Structure, and Cytotoxicity

  2017cites this paper
• ORGANOMETALLIC COMPOUNDS OF RUTHENIUM AND THEIR ANTI-CANCER PROPERTIES

  2017cites this paper
• Self-Assembly of Discrete RuII8 Molecular Cages and Their in Vitro Anticancer Activity.

  2017cites this paper
• Cationic Ru(η6‐p‐cymene) Complexes of 3‐Hydroxy‐4‐pyr(id)ones – Lipophilic Triphenylphosphine as Co‐Ligand Is Key to Highly Stable and Cytotoxic Anticancer Agents

  2017cites this paper
• Trends and Perspectives of Ruthenium Anticancer Compounds (Non‐PDT)

  2017cites this paper
• Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents.

  2017cites this paper
• Radiomodifying effects of RAPTA C and CDDP on DNA strand break induction

  2017cites this paper
• Tripodal Half‐Sandwich Rhodium and Iridium Complexes Containing Sulfonate and Pyridinyl Entities as Antitumor Agents

  2017cites this paper
• Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.

  2017cites this paper
• Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin.

  2017cites this paper
• Ruthenium Anticancer Agents—From Cisplatin Analogues to Rational Drug Design

  2017cites this paper
• Rhodium Pentamethylcyclopentadienato Complexes for Delivery of the Curcumin Anti‐Cancer Drug

  2017cites this paper
• Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments.

  2017cites this paper
• Ruthenium(II)-arene complexes with dibenzoylmethane induce apoptotic cell death in multiple myeloma cell lines

  2017cites this paper
• Preparation, characterization and evaluation of novel 1,3,5-triaza-7-phosphaadamantane (PTA)-based palladacycles as anti-cancer agents

  2017cites this paper
• Ruthenium(II) piano stool coordination compounds with aminomethylphosphanes: Synthesis, characterisation and preliminary biological study in vitro.

  2017cites this paper
• Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.

  2016cites this paper
• Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety.

  2016cites this paper
• Synthesis and Antiproliferative Activity of [RuCp(PPh3)2(HdmoPTA)](OSO2CF3)2 (HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).

  2016cites this paper
• Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.

  2016cites this paper
• Ruthenium(II) p-cymene complexes of naphthoquinone derivatives as antitumor agents: A structure−activity relationship study

  2016cites this paper
• From Sunscreen to Anticancer Agent: Ruthenium(II) Arene Avobenzone Complexes Display Potent Anticancer Activity

  2016cites this paper
• Interactions between proteins and Ru compounds of medicinal interest: A structural perspective

  2016cites this paper
• The development of RAPTA compounds for the treatment of tumors

  2016cites this paper
• Fine tuning through valence bond tautomerization of ancillary ligands in ruthenium(ii) arene complexes for better anticancer activity and enzyme inhibition properties.

  2016cites this paper
• Anticancer Organometallic Osmium(II)‐p‐cymene Complexes

  2015cites this paper
• Complexos anfifílicos de rutênio e seus filmes Langmuir-Blodgett

  2015cites this paper
• Organoruthenium and Osmium Anticancer Complexes Bearing a Maleimide Functional Group: Reactivity to Cysteine, Stability, and Cytotoxicity

  2015cites this paper
• Development of ruthenium-based complexes as anticancer agents: toward a rational design of alternative receptor targets

  2015influential citation
• Dinuclear (η6-arene) ruthenium(II) acylpyrazolone complexes: Synthesis, characterization and cytotoxicity

  2015cites this paper
• The fungal natural product (1S,3S)-austrocortirubin induces DNA damage in HCT116 cells via a mechanism unique from other DNA damaging agents.

  2015cites this paper
• Arene ruthenium(II) complexes with 2-acetamidothiazole derived ligands: Synthesis, structural studies, antifouling and antibacterial properties

  2015cites this paper
• Anticancer Activity and Autophagy Involvement of Self-Assembled Arene-Ruthenium Metallacycles

  2015cites this paper
• Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.

  2015cites this paper
• Designing Prodrugs Based on Special Residues of Human Serum Albumin.

  2015cites this paper
• Ruthenium(II)-arene complexes with naphthalimide-tagged N,O- and N,N-chelating ligands: Synthesis and biological evaluation

  2015cites this paper
• Photoinduced interactions of supramolecular ruthenium(II) complexes with plasmid DNA: synthesis and spectroscopic, electrochemical, and DNA photocleavage studies.

  2015cites this paper
• Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.

  2014cites this paper